Get started
Author

Hana Kopecka

Observed names: H Kopecka, H. KOPECKA, H. Kopecka, H. Kopecká, HANA KOPECKA
OpenAlex ID: A5084977296
Vancomycin: structure and transformation to CDP-I
1983 · Constance M. Harris, Hana Kopecka, et al. · Journal of the American Chemical Society · 224
The role of the chlorine substituents in the antibiotic vancomycin: preparation and characterization of mono- and didechlorovancomycin
1985 · Constance M. Harris, Rajamoorthi Kannan, et al. · Journal of the American Chemical Society · 162
A Short, Efficient Synthesis of the Novel Cholinergic Channel Activator, ABT 418, from L-Proline
1995 · Richard L. Elliott, Hana Kopecka, et al. · Synthesis · 51
Synthesis of N-arylated oxazolidinones via a palladium catalyzed cross coupling reaction. Application to the synthesis of the antibacterial agent Dup-721
2001 · David J Madar, Hana Kopecka, et al. · Tetrahedron Letters · 49
Development of CCK-tetrapeptide analogs as potent and selective CCK-A receptor agonists
1990 · Kazumi Shiosaki, Chun Wel Lin, et al. · Journal of Medicinal Chemistry · 45
Evidence that type A CCK receptors facilitate dopamine efflux in rat brain
1988 · Thomas W. Vickroy, Bruce R. Bianchi, et al. · European Journal of Pharmacology · 45
Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit
2007 · Bradley J. Backes, Kenton Longenecker, et al. · Bioorganic & Medicinal Chemistry Letters · 39
Discovery of 2-[4-{{2-(2S,5R)-2-Cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl]amino]- 4-methyl-1-piperidinyl]-4-pyridinecarboxylic Acid (ABT-279): A Very Potent, Selective, Effective, and Well-Tolerated Inhibitor of Dipeptidyl Peptidase-IV, Useful for the Treatment of Diabetes
2006 · David J. Madar, Hana Kopecka, et al. · Journal of Medicinal Chemistry · 37
Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
1991 · C W Lin, K Shiosaki, et al. · Molecular Pharmacology · 34
Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists
1989 · James F. Kerwin, Alex M. Nadzan, et al. · Journal of Medicinal Chemistry · 31
Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-A receptor agonists
1991 · Kazumi Shiosaki, Chun Wel Lin, et al. · Journal of Medicinal Chemistry · 28
Discovery of Ascomycin Analogs with Potent Topical but Weak Systemic Activity for Treatment of Inflammatory Skin Diseases
1998 · Karl W. Mollison, Thomas A. Fey, et al. · Current Pharmaceutical Design · 24
Cholecystokinin (CCK) antagonists: (R)-tryptophan-based hybrid antagonists of high affinity and selectivity for CCK-A receptors
1991 · James F. Kerwin, Frank Wagenaar, et al. · Journal of Medicinal Chemistry · 24
Cholecystokinin receptors: relationships among phosphoinositide breakdown, amylase release and receptor affinity in pancreas.
1986 · C W Lin, B R Bianchi, et al. · Journal of Pharmacology and Experimental Therapeutics · 23
2-(Aryloxymethyl) azacyclic analogues as novel nicotinic acetylcholine receptor (nAChR) ligands
1996 · Richard L. Elliott, Hana Kopecka, et al. · Bioorganic & Medicinal Chemistry Letters · 22
The stabilization of vancomycin by peptidoglycan analogs.
1985 · CONSTANCE M. HARRIS, HANA KOPECKA, et al. · The Journal of Antibiotics · 20
PDF
Centrally administered CCK-8 suppresses activity in mice by a “peripheral-type” CCK receptor
1989 · D.R. Britton, L. Yahiro, et al. · Pharmacology Biochemistry and Behavior · 18
Tetrapeptide CCK-A Agonists: Effect of Backbone N-Methylations on in vitro and in vivo CCK Activity
1994 · Mark W. Holladay, Hana Kopecka, et al. · Journal of Medicinal Chemistry · 16
A short, efficient chiral synthesis of a novel cholinergic channel activator, ABT-418 [(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole], from (S)-pyroglutamic acid
1995 · Nan-Horng Lin, Yun He, et al. · Tetrahedron Letters · 14
Double bond isosteres of the peptide bond: Synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs
1993 · Youe-Kong Shue, Michael D. Tufano, et al. · Bioorganic & Medicinal Chemistry · 11
Tetrapeptide CCK agonists: structure-activity studies on modifications at the N-terminus
1994 · Richard L. Elliott, Hana Kopecka, et al. · Journal of Medicinal Chemistry · 10
Novel Asp32-Replacement Tetrapeptide Analogs as Potent and Selective CCK-A Agonists
1994 · Richard L. Elliott, Hana Kopecka, et al. · Journal of Medicinal Chemistry · 9
Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N.epsilon.)-amide residues
1992 · Kazumi Shiosaki, Chun Wel Lin, et al. · Journal of Medicinal Chemistry · 8
Thermal decomposition of 10,11-methylenedioxy-3,4,12-trimethoxy-7,8,13,13a-tetrahydro-5H-isoindolo[1,2-b] [3]benzazepine methohydroxide
1975 · Z. Veselý, J. Holubek, et al. · Collection of Czechoslovak Chemical Communications · 4
Minor Structural Differences in Boc-CCK-4 Derivatives Dictate Affinity and Selectivity for CCK-A and CCK-B Receptors
1997 · Kazumi Shiosaki, Chun Wel Lin, et al. · Journal of Medicinal Chemistry · 3
Works count: 38
Citation count: 957
H-index: 17
I10-index: 21
Year
Topic
Type